Global Orphan Lung Diseases Treatment Market Research Report 2023

Report ID: 1917411 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Immunosuppressants
        1.2.3 Anti-Inflammatory Drugs
        1.2.4 Anti-Fibrotic Agents
        1.2.5 Vasodilators
        1.2.6 Corticosteroids
        1.2.7 CFTR Modulators
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Orphan Lung Diseases Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Orphan Lung Diseases Treatment Market Perspective (2017-2028)
    2.2 Orphan Lung Diseases Treatment Growth Trends by Region
        2.2.1 Orphan Lung Diseases Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Orphan Lung Diseases Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Orphan Lung Diseases Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Orphan Lung Diseases Treatment Market Dynamics
        2.3.1 Orphan Lung Diseases Treatment Industry Trends
        2.3.2 Orphan Lung Diseases Treatment Market Drivers
        2.3.3 Orphan Lung Diseases Treatment Market Challenges
        2.3.4 Orphan Lung Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Orphan Lung Diseases Treatment Players by Revenue
        3.1.1 Global Top Orphan Lung Diseases Treatment Players by Revenue (2017-2022)
        3.1.2 Global Orphan Lung Diseases Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Orphan Lung Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Orphan Lung Diseases Treatment Revenue
    3.4 Global Orphan Lung Diseases Treatment Market Concentration Ratio
        3.4.1 Global Orphan Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Orphan Lung Diseases Treatment Revenue in 2021
    3.5 Orphan Lung Diseases Treatment Key Players Head office and Area Served
    3.6 Key Players Orphan Lung Diseases Treatment Product Solution and Service
    3.7 Date of Enter into Orphan Lung Diseases Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Orphan Lung Diseases Treatment Breakdown Data by Type
    4.1 Global Orphan Lung Diseases Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Orphan Lung Diseases Treatment Forecasted Market Size by Type (2023-2028)
5 Orphan Lung Diseases Treatment Breakdown Data by Application
    5.1 Global Orphan Lung Diseases Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Orphan Lung Diseases Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Orphan Lung Diseases Treatment Market Size (2017-2028)
    6.2 North America Orphan Lung Diseases Treatment Market Size by Country (2017-2022)
    6.3 North America Orphan Lung Diseases Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Orphan Lung Diseases Treatment Market Size (2017-2028)
    7.2 Europe Orphan Lung Diseases Treatment Market Size by Country (2017-2022)
    7.3 Europe Orphan Lung Diseases Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Orphan Lung Diseases Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Orphan Lung Diseases Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Orphan Lung Diseases Treatment Market Size (2017-2028)
    9.2 Latin America Orphan Lung Diseases Treatment Market Size by Country (2017-2022)
    9.3 Latin America Orphan Lung Diseases Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Orphan Lung Diseases Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GSK
        11.1.1 GSK Company Detail
        11.1.2 GSK Business Overview
        11.1.3 GSK Orphan Lung Diseases Treatment Introduction
        11.1.4 GSK Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.1.5 GSK Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Orphan Lung Diseases Treatment Introduction
        11.2.4 Pfizer Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Celgene
        11.3.1 Celgene Company Detail
        11.3.2 Celgene Business Overview
        11.3.3 Celgene Orphan Lung Diseases Treatment Introduction
        11.3.4 Celgene Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.3.5 Celgene Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Orphan Lung Diseases Treatment Introduction
        11.4.4 Novartis Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 NPS Pharmaceuticals
        11.5.1 NPS Pharmaceuticals Company Detail
        11.5.2 NPS Pharmaceuticals Business Overview
        11.5.3 NPS Pharmaceuticals Orphan Lung Diseases Treatment Introduction
        11.5.4 NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.5.5 NPS Pharmaceuticals Recent Development
    11.6 Auspex Pharmaceuticals
        11.6.1 Auspex Pharmaceuticals Company Detail
        11.6.2 Auspex Pharmaceuticals Business Overview
        11.6.3 Auspex Pharmaceuticals Orphan Lung Diseases Treatment Introduction
        11.6.4 Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.6.5 Auspex Pharmaceuticals Recent Development
    11.7 Synageva BioPharma
        11.7.1 Synageva BioPharma Company Detail
        11.7.2 Synageva BioPharma Business Overview
        11.7.3 Synageva BioPharma Orphan Lung Diseases Treatment Introduction
        11.7.4 Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.7.5 Synageva BioPharma Recent Development
    11.8 Roche
        11.8.1 Roche Company Detail
        11.8.2 Roche Business Overview
        11.8.3 Roche Orphan Lung Diseases Treatment Introduction
        11.8.4 Roche Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.8.5 Roche Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Detail
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Orphan Lung Diseases Treatment Introduction
        11.9.4 Sanofi Revenue in Orphan Lung Diseases Treatment Business (2017-2022)
        11.9.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Orphan Lung Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Immunosuppressants
    Table 3. Key Players of Anti-Inflammatory Drugs
    Table 4. Key Players of Anti-Fibrotic Agents
    Table 5. Key Players of Vasodilators
    Table 6. Key Players of Corticosteroids
    Table 7. Key Players of CFTR Modulators
    Table 8. Key Players of Others
    Table 9. Global Orphan Lung Diseases Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Orphan Lung Diseases Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Orphan Lung Diseases Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Orphan Lung Diseases Treatment Market Share by Region (2017-2022)
    Table 13. Global Orphan Lung Diseases Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Orphan Lung Diseases Treatment Market Share by Region (2023-2028)
    Table 15. Orphan Lung Diseases Treatment Market Trends
    Table 16. Orphan Lung Diseases Treatment Market Drivers
    Table 17. Orphan Lung Diseases Treatment Market Challenges
    Table 18. Orphan Lung Diseases Treatment Market Restraints
    Table 19. Global Orphan Lung Diseases Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Orphan Lung Diseases Treatment Market Share by Players (2017-2022)
    Table 21. Global Top Orphan Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Lung Diseases Treatment as of 2021)
    Table 22. Ranking of Global Top Orphan Lung Diseases Treatment Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Orphan Lung Diseases Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Orphan Lung Diseases Treatment Product Solution and Service
    Table 26. Date of Enter into Orphan Lung Diseases Treatment Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Orphan Lung Diseases Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Orphan Lung Diseases Treatment Revenue Market Share by Type (2017-2022)
    Table 30. Global Orphan Lung Diseases Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Orphan Lung Diseases Treatment Revenue Market Share by Type (2023-2028)
    Table 32. Global Orphan Lung Diseases Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Orphan Lung Diseases Treatment Revenue Market Share by Application (2017-2022)
    Table 34. Global Orphan Lung Diseases Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Orphan Lung Diseases Treatment Revenue Market Share by Application (2023-2028)
    Table 36. North America Orphan Lung Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Orphan Lung Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Orphan Lung Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe Orphan Lung Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific Orphan Lung Diseases Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America Orphan Lung Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America Orphan Lung Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa Orphan Lung Diseases Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 46. GSK Company Detail
    Table 47. GSK Business Overview
    Table 48. GSK Orphan Lung Diseases Treatment Product
    Table 49. GSK Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 50. GSK Recent Development
    Table 51. Pfizer Company Detail
    Table 52. Pfizer Business Overview
    Table 53. Pfizer Orphan Lung Diseases Treatment Product
    Table 54. Pfizer Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 55. Pfizer Recent Development
    Table 56. Celgene Company Detail
    Table 57. Celgene Business Overview
    Table 58. Celgene Orphan Lung Diseases Treatment Product
    Table 59. Celgene Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 60. Celgene Recent Development
    Table 61. Novartis Company Detail
    Table 62. Novartis Business Overview
    Table 63. Novartis Orphan Lung Diseases Treatment Product
    Table 64. Novartis Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 65. Novartis Recent Development
    Table 66. NPS Pharmaceuticals Company Detail
    Table 67. NPS Pharmaceuticals Business Overview
    Table 68. NPS Pharmaceuticals Orphan Lung Diseases Treatment Product
    Table 69. NPS Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 70. NPS Pharmaceuticals Recent Development
    Table 71. Auspex Pharmaceuticals Company Detail
    Table 72. Auspex Pharmaceuticals Business Overview
    Table 73. Auspex Pharmaceuticals Orphan Lung Diseases Treatment Product
    Table 74. Auspex Pharmaceuticals Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 75. Auspex Pharmaceuticals Recent Development
    Table 76. Synageva BioPharma Company Detail
    Table 77. Synageva BioPharma Business Overview
    Table 78. Synageva BioPharma Orphan Lung Diseases Treatment Product
    Table 79. Synageva BioPharma Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 80. Synageva BioPharma Recent Development
    Table 81. Roche Company Detail
    Table 82. Roche Business Overview
    Table 83. Roche Orphan Lung Diseases Treatment Product
    Table 84. Roche Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 85. Roche Recent Development
    Table 86. Sanofi Company Detail
    Table 87. Sanofi Business Overview
    Table 88. Sanofi Orphan Lung Diseases Treatment Product
    Table 89. Sanofi Revenue in Orphan Lung Diseases Treatment Business (2017-2022) & (US$ Million)
    Table 90. Sanofi Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Orphan Lung Diseases Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Immunosuppressants Features
    Figure 3. Anti-Inflammatory Drugs Features
    Figure 4. Anti-Fibrotic Agents Features
    Figure 5. Vasodilators Features
    Figure 6. Corticosteroids Features
    Figure 7. CFTR Modulators Features
    Figure 8. Others Features
    Figure 9. Global Orphan Lung Diseases Treatment Market Share by Application in 2021 & 2028
    Figure 10. Hospital Pharmacies Case Studies
    Figure 11. Retail Pharmacies Case Studies
    Figure 12. Online Pharmacies Case Studies
    Figure 13. Orphan Lung Diseases Treatment Report Years Considered
    Figure 14. Global Orphan Lung Diseases Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Orphan Lung Diseases Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Orphan Lung Diseases Treatment Market Share by Region: 2021 VS 2028
    Figure 17. Global Orphan Lung Diseases Treatment Market Share by Players in 2021
    Figure 18. Global Top Orphan Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Lung Diseases Treatment as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Orphan Lung Diseases Treatment Revenue in 2021
    Figure 20. North America Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Orphan Lung Diseases Treatment Market Share by Country (2017-2028)
    Figure 22. United States Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Orphan Lung Diseases Treatment Market Share by Country (2017-2028)
    Figure 26. Germany Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Orphan Lung Diseases Treatment Market Share by Region (2017-2028)
    Figure 34. China Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Orphan Lung Diseases Treatment Market Share by Country (2017-2028)
    Figure 42. Mexico Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Orphan Lung Diseases Treatment Market Share by Country (2017-2028)
    Figure 46. Turkey Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Orphan Lung Diseases Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. GSK Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 49. Pfizer Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 50. Celgene Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 51. Novartis Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 52. NPS Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 53. Auspex Pharmaceuticals Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 54. Synageva BioPharma Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 55. Roche Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Orphan Lung Diseases Treatment Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Pfizer
Celgene
Novartis
NPS Pharmaceuticals
Auspex Pharmaceuticals
Synageva BioPharma
Roche
Sanofi
Frequently Asked Questions
Orphan Lung Diseases Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Orphan Lung Diseases Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Orphan Lung Diseases Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Orris Oil

Orris oil is extracted from the irises roots particularly called as (Iris germanica) which is a t ... Read More

Orris Concrete

Orris Concrete or named orris oil,is extracted from the irises roots particularly called as (Iris ... Read More